Luxury Once Sold Escape - Longevity Sells Capacity.

For decades, luxury health meant leaving your life behind. The thermal spa, the white robe, the promise of switching off. Wellness was somewhere you escaped to, usually once a year, and its value was measured in ambience. That model is giving way. Today’s affluent consumer is less interested in which treatment to book than in what it will do to their biology, and how they will know it worked. “Luxury once sold escape. Longevity sells capacity,” says Maila Reeves, co-founder and CEO of science-led longevity company Bio Atelier .

This is the Infrastructure Shift: health is moving from occasional indulgence to everyday infrastructure, built into where people live, work, travel and stay, and the money is following.

A $6.8 Trillion Wellness Market With Structural Momentum

The Global Wellness Institute values the global wellness economy at $6.8 trillion in 2024 and forecasts it will reach $9.8 trillion by 2029. McKinsey puts the consumer wellness market at around $2 trillion. Up to 60% of consumers in surveyed markets now describe healthy ageing as a top or very important priority, and personalised medicine is forecast to grow 9.3% a year through 2029. What matters is what drives that growth. Ageing populations, rising chronic disease, demand for prevention and rapid advances in diagnostics are structural forces, not a passing fashion.

"A trend tells us what is becoming fashionable, but a pattern tells us what may become inevitable.” Maila Reeves

Luxury used to buy ambience and exclusivity. At its best, it now buys formulation rigour, personalisation, expert interpretation and continuity. Consumers are driving the change. McKinsey found that roughly half of UK and US consumers rank clinical effectiveness as a leading purchase factor for wellness products, while only about 20% say the same of natural or “clean” ingredients. The market is moving from claims to credible efficacy.

Longevity and wellness businesses have cornered the premium market often with beautiful packaging and many promises. Reeves argues the longevity sector has an information problem, information is not scarce, but it is increasingly important to differentiate between opinion and data, and, access trustworthy data. Asia is experiencing a boom in high-end longevity clinics , where it is reported that public consumption is outpacing the science. Credibility is the real premium and creating products that support the wider market will become increasingly important to sustain the wellbeing of the wider population.

The stereotype of the longevity customer, a male biohacker surrounded by monitors, no longer holds. Millennials and Gen Z make up 36% of the US adult population but drive more than 41% of annual wellness spending. Executives increasingly treat energy and cognitive capacity as business assets. Athletes think about career longevity, not only peak performance. Bio Atelier, the company co-founded by Reeves, has been working on pioneering products and collaborating with leading researchers and medical innovators who helped shape the global understanding of cellular health. Its client base demonstrates the spread: doctors buying for themselves, a 19-year-old, perimenopausal women and older men, each at a different biological chapter. What unites them is not a wish to live forever. It is a wish to function better now and protect what matters later. Reeves explains how her clients behave: “Health has moved from the margins of someone’s life into the architecture of it. We are seeing repeat orders from clinics and practitioners at almost 100%.”

Women’s Healthspan: A Market Failure In Plain Sight

Women have long been treated as a niche, despite being half the population and making a large share of household health decisions. The gaps run across research, diagnosis, treatment and product development. Hormonal stages affect sleep, cognition, metabolism, bone health and cardiovascular risk, yet many women navigate them with fragmented information and little continuity.

The economic case is substantial. Closing the women’s health gap could unlock at least $1 trillion in annual global economic growth by 2040, equivalent to roughly seven additional healthy days per woman each year. This is clearly a market failure, and it builds on a raft of evidence of the neglect of women’s health and wellbeing.

One area that has recently been the focus of women’s health and wellbeing is menopausal health , with an emphasis on long-term health rather than relying on symptom relief alone. As the evidence shows, products need to be clearly tailored to the biological needs of women, through individual and clinical assessments. Pink-washing products will not yield results or create longer-term business opportunities.

Beyond The Wellness Clinics

The Infrastructure Shift is most visible in where health is delivered. Longevity is moving into residences, hotels, membership clubs and travel, from wellness resorts to superyachts. Wellness real estate reached $584 billion in 2024 and is forecast to double to $1.1 trillion by 2029 , growing more than three times faster than construction overall, according to the Global Wellness Institute. In Dubai, One&Only has opened a longevity hub with Swiss clinic Clinique La Prairie, while superyatch builders now design hyperbaric chambers and ice baths into new vessels.

The GCC and parts of Asia are moving fastest. They treat health, hospitality, real estate and technology as one system, and are less attached to the idea that healthcare belongs only in a hospital. The UAE and Saudi Arabia have been the two fastest-growing wellness markets in the world since 2019, according to the Global Wellness Institute’s 2026 Country Rankings, with Saudi Arabia’s wellness economy expanding at twice the global rate.

Even through this year’s regional economic downturn, the long-term bet on wellness infrastructure is clear. In Asia, where longevity is often framed more holistically, blending modern diagnostics with traditional healing and high-touch hospitality, luxury hotels are adding longevity clinics at pace. “The next frontier of luxury travel is not how beautifully you depart,” Reeves says. “It is how well you arrive.” Speed carries its own risk, and the winners will pair ambition with clinical credibility.

Here sits the central tension. The best diagnostics, expertise and personalised protocols remain concentrated among people with money, time and proximity to the right clinics. Call it the Longevity Gap: the distance between what longevity science can do and who it actually reaches.

The gap shows up in the workplace too. While luxury longevity booms, the Global Wellness Institute found workplace wellness was the only stagnant segment of the wellness economy, with global spending falling 1.5% between 2023 and 2024. Employers have moved away from structured programmes, and the rise of remote and gig work has left more people without access to any wellness benefits at all. Luxury markets can act as testing grounds, where costs fall and technologies mature before reaching the mainstream. But that progression is not automatic. “Luxury may be the laboratory,” Reeves says. “It cannot be the final destination.”

There is a hard business case for closing the gap. McKinsey estimates that every $1 invested in healthy ageing interventions in the US could generate about $3 in economic and healthcare benefits. Employers, health systems and governments all have a stake in where this market goes next.

Longevity - From Indulgence To Integration

The marker of luxury health is no longer the spa robe; it’s the intelligence and discipline behind the outcome. The next phase is integration. Diagnostics, artificial intelligence, wearables and personalised nutrition are already sophisticated; the experience of making sense of them is not. As Reeves puts it, people need “context, continuity and proportion.” The businesses that win will build health that travels with people and adapts to their lives, rather than another product sitting in isolation.

For an industry selling capacity, the test is simple: results and innovation matter.